Article in ImmunoHorizons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 1 country.
Saara KavianyDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-2838-8214
Todd BartkowiakVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-2396-0197
Daniel E DulekDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-1821-6657
Yasmin W KhanDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Madeline J HayesVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-3684-9885
Samuel G SchaeferVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8175-1791
Xiang YeDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8694-8710
Debolanle O DahunsiVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-5230-022X
James A ConnellyDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-7223-375X
Jonathan M IrishVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN; jonathan.irish@vanderbilt.edu jeff.rathmell@vumc.org.
Jeffrey C RathmellVanderbilt Human Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN; jonathan.irish@vanderbilt.edu jeff.rathmell@vumc.org.ORCID 0000-0002-4106-3396
Vanderbilt University Medical Center · USVanderbilt University · US
Funding
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Single Cell Methods for Bioeffector Discovery and AnalysisR01CA226833 · NCI · VANDERBILT UNIVERSITY · PI BRIAN O BACHMANN, Jonathan Michael Irish · 2019 to 2026
$6.1M
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory diseaseR01DK105550 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey C Rathmell · 2015 to 2026
$4.7M
Targeting Tfh Cell Metabolic Regulation in SLE and SLE-Associated AtherosclerosisR01AI153167 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MAJOR, AMY S, RATHMELL, JEFFREY C. · 2020 to 2024
$2.8M
Memory potential, molecular characterization, and translational applications of the novel ThEO/TcEO T cell phenotypeK00CA212447 · NCI · VANDERBILT UNIVERSITY · PI BARTKOWIAK, TODD · 2018 to 2021
$309k
Memory potential, molecular characterization, and translational applications of the novel ThEO/TcEO T cell phenotypeF99CA212447 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BARTKOWIAK, TODD · 2016 to 2017
ImmunitySTAT1 Transcription FactorCytokinesGain of Function MutationHumansInterleukin-6PhenotypePhosphorylationCytokinesInterleukin-6STAT1 protein, humanSTAT1 Transcription Factor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Systems Immunology Analyses of · full record | OpenQuestion